-+ 0.00%
-+ 0.00%
-+ 0.00%

BOUNDLESS BIO INC: PORTFOLIO PRIORITIZATION, INCLUDING DISCONTINUATION OF POTENTIATE TRIAL, EXTENDS OPERATING RUNWAY INTO H2 2028

Reuters·01/20/2026 12:05:04

Please log in to view news